SEPTEMBER 2022 PUBLICATION IN STROKE:
Pharmacological Characterization of a Novel Neuroactive Steroid Prodrug, NTS-104, and Its Neuroprotective Activity in Experimental Stroke Models
Transforming the treatment of Stroke and Traumatic Brain Injury.